DeVivo takes over the corner office at AngioDynamics

AngioDynamics Inc. (NSDQ:ANGO) named a replacement for former CEO Jan Keltjens, who left suddenly in June, tapping Joseph DeVivo for the corner office.

The Latham, N.Y.-based oncology device company also revealed the resignation of senior vice president of business development Lynda Wallace, according to SEC filings.

DeVivo, formerly president of Smith & Nephew plc’s (NYSE:SNN) orthopedic division, took over as AngioDynamics chief last month, three days before Wallace’s resignation was filed with the SEC.

Sign up to get our free newsletters delivered right to your inbox.

Keltjens announced his resignation immediately after AngioDynamics released a lackluster fourth quarter and fiscal year earnings report.

Wallace took the position in May 2010, reporting directly to Keltjens. No reason was given for Wallace’s decision to leave and AngioDynamics did not immediately respond to requests for comment. The company also named Alan Panzer as the senior VP and general manager for its vascular access, surgery, peripheral vascular disease and oncology division.

There’s been a lot of turnover at the Latham HQ over the past year or so. Former AngioDynamics vice president Shawn McCarthy now inhabits the corner office at Durham, N.C.-based stent maker Tryton Medical Inc.

Here are the latest personnel changes from medical device, diagnostics and life science companies around the nation. For more recent hirings and firings, check out MassDevice’s compilation of the latest personnel moves.